Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:liver/biliary measurement
go back to main search page
Accession:CMO:0000086 term browser browse the term


show annotations for term's descendants           Sort by:
 
area of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar6 Hepatocarcinoma resistance QTL 6 IDA RGD PMID:10850431 RGD:619609
liver cholesterol level term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hpcl1 Hepatic cholesterol level QTL 1 IDA RGD PMID:9600105 RGD:629576 NCBI chr10:36,584,373...53,645,194 JBrowse link
Q Hpcl2 Hepatic cholesterol level QTL 2 IDA RGD PMID:18071061 RGD:1643359 NCBI chr10:46,593,021...98,939,209 JBrowse link
liver copper weight to liver dry weight ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcuc1 Hepatic copper content QTL 1 IDA RGD PMID:11741328 RGD:619607
Q Hcuc3 Hepatic copper content QTL 3 IDA RGD PMID:12094018 RGD:629572 NCBI chr 2:245,893,572...266,435,125 JBrowse link
Q Hcuc4 Hepatic copper content QTL 4 IDA RGD PMID:12094018 RGD:629572 NCBI chr10:69,348,459...75,983,662 JBrowse link
liver nonremodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA RGD PMID:15185337 RGD:737884 NCBI chr18:53,033,494...87,080,053 JBrowse link
liver nonremodeling tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA RGD PMID:15185337 RGD:737884 NCBI chr 4:1...31,554,484 JBrowse link
Q Hcas6 Hepatocarcinoma susceptibility QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr14:61,873,323...88,870,994 JBrowse link
Q Hcas7 Hepatocarcinoma susceptibility QTL 7 IDA RGD PMID:15185337 RGD:737884 NCBI chr15:2,327,877...53,535,766 JBrowse link
liver remodeling tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,179,397 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:1...47,622,148 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:65,008,245...91,629,354 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:80,403,559...91,629,354 JBrowse link
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA RGD PMID:12672032 RGD:629574 NCBI chr 7:40,872,682...85,872,682 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA RGD PMID:12672032 RGD:629574 NCBI chr 1:255,728,828...282,763,074 JBrowse link
liver total copper weight term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcuc2 Hepatic copper content QTL 2 IDA RGD PMID:11741328 RGD:619607 NCBI chr16:1...41,240,957 JBrowse link
liver tumorous lesion area to total liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:71,476,518...116,476,518 JBrowse link
Q Hcar8 Hepatocarcinoma resistance QTL 8 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:123,478,354...168,478,354 JBrowse link
liver tumorous lesion number term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA RGD PMID:12154055 RGD:629566 NCBI chr 8:44,219,197...89,542,960 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA RGD PMID:12154055 RGD:629566 NCBI chr 6:86,422,697...115,379,601 JBrowse link
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:163,796,316...282,763,074 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:236,763,415...247,065,599 JBrowse link
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:71,476,518...116,476,518 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 1:5,655,769...122,614,963 JBrowse link
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr 1:191,825,895...279,986,079 JBrowse link
Q Hcas8 Hepatocarcinoma susceptibility QTL 8 IDA RGD PMID:17079458 RGD:1599590 NCBI chr16:1...24,228,366 JBrowse link
liver tumorous lesion number to liver area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:210,960,636...236,763,528 JBrowse link
liver tumorous lesion volume to total liver volume ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr 7:100,160,423...140,335,001 JBrowse link
Q Hcas3 Hepatocarcinoma susceptibility QTL 3 IDA RGD PMID:12154055 RGD:629566 NCBI chr 1:156,446,196...243,311,614 JBrowse link
liver weight term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Livw4 Liver weight QTL 4 IDA RGD PMID:25296178 RGD:10402111 NCBI chr 7:78,758,303...80,297,776 JBrowse link
liver weight as percentage of body weight term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Livw1 Liver weight QTL 1 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 1:166,100,317...188,289,386 JBrowse link
Q Livw2 Liver weight QTL 2 IDA RGD PMID:15728334 RGD:1580752 NCBI chr 5:102,498,468...123,852,688 JBrowse link
liver weight to body weight ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Livw3 Liver weight QTL 3 IDA RGD PMID:19526527 RGD:2316974 NCBI chr 8:7,368,076...52,368,076 JBrowse link
volume of individual liver tumorous lesion term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr10:6,229,289...36,185,929 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA RGD PMID:12154055 RGD:629566 NCBI chr 3:30,114,912...123,700,444 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 4:79,555,067...124,555,067 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA RGD PMID:10493520 RGD:619598 NCBI chr 8:58,425,510...106,526,740 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA RGD PMID:12154055 RGD:629566 NCBI chr 4:105,971,071...168,047,091 JBrowse link
Q Hcas4 Hepatocarcinoma susceptibility QTL 4 IDA RGD PMID:12154055 RGD:629566 NCBI chr16:5,013,802...50,169,318 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    liver/biliary measurement 39
      liver measurement + 39
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.